Literature DB >> 15338010

E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.

Xiao-Mei Rao1, Michael T Tseng, Xinyu Zheng, Yanbin Dong, Azemat Jamshidi-Parsian, Timothy C Thompson, Malcolm K Brenner, Kelly M McMasters, Heshan Sam Zhou.   

Abstract

Apoptotic pathways are initiated as a cellular defense mechanism to eliminate adenovirus-infected cells. We have investigated how E1A-induced apoptosis interferes with viral replication in cancer cells. We found that E1B19K alone can efficiently suppress E1A-induced apoptosis in cancer cells. Viruses deleted for both E1B19K and E1B55K resulted in cellular DNA degradation. However, less than 20% of human lung cancer cells infected with a virus deleted for both E1B19K and E1B55 K had evidence of chromatin condensation and multiple-micronuclei formation (apoptotic hallmarks); these cells could not produce infectious viral particles. The majority of cancer cells infected with viruses deleted for the entire E1b gene did not undergo extended apoptosis and produced abundant viral progeny. Thus, only a fraction of cancer cells underwent apoptosis and did not allow E1b-deleted viruses to replicate, while the majority of cancer cells were resistant to E1A-induced apoptosis and could support virus-selective replication. The results of this study imply that, in addition to inhibiting E1A-induced apoptosis, E1B proteins may contribute other important roles in the viral life cycle. Our results also suggest that combining virus-induced apoptosis and selective viral replication into one vector will be a novel approach to destroy cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338010     DOI: 10.1038/sj.cgt.7700739

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  19 in total

1.  The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.

Authors:  Stephen L Wechman; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Heshan Sam Zhou; Kelly M McMasters
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

2.  Adenoviruses induce autophagy to promote virus replication and oncolysis.

Authors:  Humberto Rodriguez-Rocha; Jorge G Gomez-Gutierrez; Aracely Garcia-Garcia; Xiao-Mei Rao; Lan Chen; Kelly M McMasters; Heshan Sam Zhou
Journal:  Virology       Date:  2011-05-14       Impact factor: 3.616

3.  Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.

Authors:  Jorge G Gomez-Gutierrez; Xiao-Mei Rao; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2012-09-27       Impact factor: 3.616

4.  Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.

Authors:  Rodolfo Garza-Morales; Kavitha Yaddanapudi; Rigoberto Perez-Hernandez; Eric Riedinger; Kelly M McMasters; Haval Shirwan; Esma Yolcu; Roberto Montes de Oca-Luna; Jorge G Gomez-Gutierrez
Journal:  Cancer Biol Ther       Date:  2018-01-22       Impact factor: 4.742

5.  Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.

Authors:  Pei-Hsin Cheng; Xiao-Mei Rao; Xiaoxian Duan; Xiao-Feng Li; Michael E Egger; Kelly M McMasters; H Sam Zhou
Journal:  J Mol Med (Berl)       Date:  2014-11-08       Impact factor: 4.599

Review 6.  Adenoviral vectors for prodrug activation-based gene therapy for cancer.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

7.  Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.

Authors:  Xinyu Zheng; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

8.  Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

Authors:  Stephan Leitner; Katrina Sweeney; Daniel Oberg; Derek Davies; Enrique Miranda; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

9.  Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis.

Authors:  Elvis Martinez-Jaramillo; Rodolfo Garza-Morales; Stephen L Wechman; Roberto Montes de Oca-Luna; Odila Saucedo-Cardenas; Haval Shirwan; Esma Yolcu; Kelly M McMasters; Jorge G Gomez-Gutierrez
Journal:  Cancer Invest       Date:  2018-02-01       Impact factor: 2.176

10.  Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Jonathan Nitz; Rajesh Sharma; Stephen L Wechman; Eric Riedinger; Elvis Martinez-Jaramillo; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2015-11-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.